Solvonis Therapeutics AWKNF Stock
Solvonis Therapeutics Price Chart
Solvonis Therapeutics AWKNF Financial and Trading Overview
| Solvonis Therapeutics stock price | 0.07 USD |
| Previous Close | 0.17 USD |
| Open | 0.21 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.14 - 0.21 USD |
| 52 Week Range | 0.09 - 0.72 USD |
| Volume | 29.41K USD |
| Avg. Volume | 18.93K USD |
| Market Cap | 5.85M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.95 USD |
AWKNF Valuation Measures
| Enterprise Value | 6.4M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.6958333 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.338098 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3.653 |
| Enterprise Value/EBITDA | -0.794 |
Trading Information
Solvonis Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -68.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.72 USD |
| 52 Week Low | 0.09 USD |
| 50-Day Moving Average | 0.22 USD |
| 200-Day Moving Average | 0.28 USD |
AWKNF Share Statistics
| Avg. Volume (3 month) | 18.93K USD |
| Avg. Daily Volume (10-Days) | 32K USD |
| Shares Outstanding | 35.04M |
| Float | 19.29M |
| Short Ratio | N/A |
| % Held by Insiders | 1.91% |
| % Held by Institutions | 8.34% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2023 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | January 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -484.65% |
| Gross Margin | -94.13% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -87.31% |
| Return on Equity (ttm) | -597.57% |
Income Statement
| Revenue (ttm) | 1.75M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 101.79% |
| Gross Profit (ttm) | N/A |
| EBITDA | -8067242 USD |
| Net Income Avi to Common (ttm) | -8014349 USD |
| Diluted EPS (ttm) | -0.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 389.7K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 2.48M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.261 |
| Book Value Per Share (mrq) | -0.029 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6130310 USD |
| Levered Free Cash Flow (ttm) | -3683961 USD |
Profile of Solvonis Therapeutics
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 301-217 Queen Street West |
| ZIP | M5V 0R2 |
| Phone | N/A |
| Website | https://awaknlifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 44 |
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.
Q&A For Solvonis Therapeutics Stock
What is a current AWKNF stock price?
Solvonis Therapeutics AWKNF stock price today per share is 0.07 USD.
How to purchase Solvonis Therapeutics stock?
You can buy AWKNF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Solvonis Therapeutics?
The stock symbol or ticker of Solvonis Therapeutics is AWKNF.
Which industry does the Solvonis Therapeutics company belong to?
The Solvonis Therapeutics industry is Biotechnology.
How many shares does Solvonis Therapeutics have in circulation?
The max supply of Solvonis Therapeutics shares is 42.19M.
What is Solvonis Therapeutics Price to Earnings Ratio (PE Ratio)?
Solvonis Therapeutics PE Ratio is now.
What was Solvonis Therapeutics earnings per share over the trailing 12 months (TTM)?
Solvonis Therapeutics EPS is -0.06 USD over the trailing 12 months.
Which sector does the Solvonis Therapeutics company belong to?
The Solvonis Therapeutics sector is Healthcare.